| abstract |
The present invention provides a pharmaceutical composition of a substituted pyridazinone compound and use thereof, wherein the substituted pyridazinone compound is a compound represented by formula (I), or a pharmaceutically acceptable salt, prodrug, Hydrates or solvates, crystal forms, stereoisomers or isotopic variants. The compounds of the present invention are THR-beta agonists and can be used for the treatment and/or prevention of diseases modulated by thyroid hormone analogs. |